logo-loader

Amryt Pharma signs exclusive Saudi Arabian distribution agreement

Published: 01:41 15 Nov 2017 AEDT

Dave Allmond, chief commercial officer at  Amryt Pharma PLC (LON:AMYT), discusses with Proactive the exclusive distribution agreement they've signed with Saudi Arabian firm Faisal Musaed El Seif Saudi Pharmaceutical Company.

The deal gives El Seif the right to distribute Amryt’s Lojuxta and AP101 drugs in the kingdom.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

10 hours, 7 minutes ago